Susquehanna International Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Susquehanna International Group’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-77,397	Closed	-$1.14M	–	13618
2024 Q1	$1.14M	Sell	77,397 -3,244	-4%	-$45.6K	﹤0.01%	6568
2023 Q4	$1.08M	Sell	80,641 -76,012	-49%	-$961K	﹤0.01%	6805
2023 Q3	$1.93M	Buy	156,653 +83,038	+113%	+$1.01M	﹤0.01%	5201
2023 Q2	$905K	Sell	73,615 -65,380	-47%	-$818K	﹤0.01%	6913
2023 Q1	$1.71M	Sell	138,995 -116,341	-46%	-$1.37M	﹤0.01%	5487
2022 Q4	$2.93M	Buy	255,336 +213,718	+514%	+$1.76M	﹤0.01%	4052
2022 Q3	$156K	Buy	41,618 +2,871	+7%	+$13.3K	﹤0.01%	11184
2022 Q2	$231K	Buy	38,747 +1,017	+3%	+$5.74K	﹤0.01%	10272
2022 Q1	$239K	Buy	37,730 +10,431	+38%	+$58.6K	﹤0.01%	10817
2021 Q4	$107K	Buy	+27,299	New	+$118K	﹤0.01%	12106
2021 Q3	–	Sell	-41,822	Closed	-$218K	–	14152
2021 Q2	$267K	Sell	41,822 -64,507	-61%	-$426K	﹤0.01%	11030
2021 Q1	$668K	Buy	106,329 +28,917	+37%	+$207K	﹤0.01%	8783
2020 Q4	$533K	Buy	77,412 +5,529	+8%	+$27.3K	﹤0.01%	8136
2020 Q3	$288K	Buy	71,883 +30,838	+75%	+$113K	﹤0.01%	8790
2020 Q2	$137K	Sell	41,045 -41,858	-50%	-$143K	﹤0.01%	9324
2020 Q1	$178K	Sell	82,903 -64,574	-44%	-$189K	﹤0.01%	8836
2019 Q4	$465K	Buy	+147,477	New	+$591K	﹤0.01%	7132
2018 Q3	–	Sell	-25,119	Closed	-$106K	–	10917
2018 Q2	$97K	Buy	+25,119	New	+$167K	﹤0.01%	9057
2018 Q1	–	Sell	-20,641	Closed	-$171K	–	10861
2017 Q4	$166K	Buy	+20,641	New	+$192K	﹤0.01%	8425
2017 Q3	–	Sell	-8,966	Closed	-$94.3K	–	10220
2017 Q2	$87K	Buy	8,966 +4,722	+111%	+$96.5K	﹤0.01%	8747
2017 Q1	$103K	Sell	4,244 -48,746	-92%	-$1.22M	﹤0.01%	8380
2016 Q4	$1.7M	Buy	52,990 +32,467	+158%	+$1.38M	﹤0.01%	4417
2016 Q3	$1.02M	Buy	+20,523	New	+$852K	﹤0.01%	4750
2016 Q2	–	Sell	-7,953	Closed	-$433K	–	9853
2016 Q1	$524K	Buy	7,953 +2,554	+47%	+$133K	﹤0.01%	6321
2015 Q4	$336K	Sell	5,399 -11,347	-68%	-$798K	﹤0.01%	7484
2015 Q3	$1.12M	Buy	16,746 +10,070	+151%	+$822K	﹤0.01%	5494
2015 Q2	$649K	Sell	6,676 -2,002	-23%	-$191K	﹤0.01%	7107
2015 Q1	$811K	Sell	8,678 -13,308	-61%	-$1.13M	﹤0.01%	6170
2014 Q4	$1.96M	Buy	21,986 +10,102	+85%	+$736K	﹤0.01%	4502
2014 Q3	$821K	Sell	11,884 -8,791	-43%	-$470K	﹤0.01%	6315
2014 Q2	$1.19M	Sell	20,675 -12,768	-38%	-$648K	﹤0.01%	5686
2014 Q1	$1.33M	Sell	33,443 -70,441	-68%	-$3.01M	﹤0.01%	5015
2013 Q4	$4.36M	Buy	103,884 +89,971	+647%	+$2.61M	﹤0.01%	3141
2013 Q3	$416K	Buy	+13,913	New	+$487K	﹤0.01%	6716

Other funds holding MACK

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Rise Advisors Rochester, New York $355M AUM 20.51% 1-Year Est. Return

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Susquehanna International Group's MACK Position: Q2 2024 in Review

Susquehanna International Group sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2024, closing a stake of 77,397 shares — an estimated $1.14M sold.

Susquehanna International Group first reported a position in MACK in Q3 2013 and held it in 34 quarters. The position peaked at $4.36M in Q4 2013. 12 funds tracked by Wall St. Rank hold MACK as of Q2 2024.

Susquehanna International Group reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2024 after selling out during the quarter.
Susquehanna International Group sold 77,397 Merrimack Pharmaceuticals, Inc. shares in Q2 2024, an estimated $1.14M.
Susquehanna International Group first reported a position in Merrimack Pharmaceuticals, Inc. in Q3 2013 and held it in 34 quarters.
Susquehanna International Group's Merrimack Pharmaceuticals, Inc. position peaked at $4.36M in Q4 2013.
12 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.